September 2016
Volume 57, Issue 12
Open Access
ARVO Annual Meeting Abstract  |   September 2016
Inhibition of Sp1 signaling promotes retinal ganglion cell death via apoptotic and necrotic pathways in a model of glaucoma
Author Affiliations & Notes
  • Kota Sato
    Ophthalmology, Tohoku University, Sendai, Miyagi, Japan
  • Yukihiro Shiga
    Ophthalmology, Tohoku University, Sendai, Miyagi, Japan
  • Kazuko Omodaka
    Ophthalmology, Tohoku University, Sendai, Miyagi, Japan
  • Shigeto Maekawa
    Ophthalmology, Tohoku University, Sendai, Miyagi, Japan
  • Namie Murayama
    Ophthalmology, Tohoku University, Sendai, Miyagi, Japan
  • Toru Nakazawa
    Ophthalmology, Tohoku University, Sendai, Miyagi, Japan
  • Footnotes
    Commercial Relationships   Kota Sato, None; Yukihiro Shiga, None; Kazuko Omodaka, None; Shigeto Maekawa, None; Namie Murayama, None; Toru Nakazawa, None
  • Footnotes
    Support  the Japanese Ministry of Education, Culture, Sports, Science, and Technology grant 26893019
Investigative Ophthalmology & Visual Science September 2016, Vol.57, 6008. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      Kota Sato, Yukihiro Shiga, Kazuko Omodaka, Shigeto Maekawa, Namie Murayama, Toru Nakazawa; Inhibition of Sp1 signaling promotes retinal ganglion cell death via apoptotic and necrotic pathways in a model of glaucoma. Invest. Ophthalmol. Vis. Sci. 2016;57(12):6008.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : The transcription factor Sp1 is known to regulate both cell survival and cell death. In this study, we examined the role of Sp1 in retinal ganglion cell (RGC) death in a mouse model of glaucoma.

Methods : Optic nerve crush was performed under general anesthesia in the right eyes of C57BL / 6J mice (8-12 weeks old). Mithramycin, an Sp1 inhibitor, was administered intravitreally immediately after optic nerve crush. The retinal gene expression of cell death-related factors was determined with real-time PCR. Retinal cell death was examined with scanning laser ophthalmoscopy (F10, NIDEK) after the vitreous injection of Sytox (3.3 μM). The number of surviving RGCs was determined with immunohistochemistry for RBPMS, an RGC marker.

Results : Two days after optic nerve crush, the retinal transcription levels of caspase-3 and c-Jun, known as apoptotic factors, rose significantly higher in the mithramycin administration group than in the control group. In addition, the gene expression of necroptotic factors, such as TNFa, TNF receptor-1, RIP1 and RIP3, also significantly increased in the mithramycin administration group. Moreover, an increase in the number of dead cells labeled with a Sytox probe was observed in the mithramycin administration group 5 days after optic nerve crush. The number of RBPMS-immunopositive RGCs also decreased in the retina 7 days after optic nerve crush.

Conclusions : Our results suggest that Sp1 activation after damage to the optic nerve works to protect against RGC dysfunction in a mouse model of glaucoma.

This is an abstract that was submitted for the 2016 ARVO Annual Meeting, held in Seattle, Wash., May 1-5, 2016.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×